November 9, 2020
A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer’s disease, which was previously thought to be undruggable. A team of researchers, led by the University of Cambridge, have identified a new mechanism of targeting amyloid-beta, a protein […]
